Sequence heterogeneity is a feature of hepatitis B virus (HBV), the prototype member of the
family Hepadnaviridae. Based on an intergroup divergence of greater than 7.5% across the …

The clinical course of infections with the hepatitis B virus (HBV) substantially varies between
individuals, as a consequence of a complex interplay between viral, host, environmental and …

Hepatitis B virus (HBV) has evolved into phylogenetically separable genotypes and
subgenotypes. Accurately assigning the subgenotype for an HBV strain is of clinical and …

Abstract Background Hepatitis B virus (HBV) infection is a global public health burden,
affecting nearly 300million people around the world. Due to HBV population is considered to …

Hepatitis B virus (HBV) is the leading cause of liver disease and infects an estimated 240
million people worldwide. It is characterised by a high degree of genetic heterogeneity …

Brazil is a country of low hepatitis B virus (HBV) endemicity in which the genotype A of HBV
(HBV/A) is the most prevalent. The complete nucleotide sequences of 26 HBV/A isolates …

Hepatitis B virus (HBV) is genetically highly divergent and classified in ten genotypes and
forty subgenotypes in distinct ethno‐geographic populations worldwide. Ethiopia is a …

Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus
(HBV). HBV-D1 is the dominant subgenotype in the Mediterranean basin, Eastern Europe …

Although hepatitis B virus (HBV) infection is hyperendemic in Ethiopia and constitutes a
major public health problem, little is known about its genetic diversity, genotypes, and …

There are currently 250 million people infected with the hepatitis B virus (HBV) worldwide,
despite the availability of a prophylactic vaccine for many years and the use of efficient and …